(PDF) Front Cover: Discovery of Vilaprisan (BAY 1002670): A

Front Cover: Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies (ChemMedChem 21/2018)

ChemMedChem - United Kingdom

doi 10.1002/cmdc.201800681

Full Text

Open PDF

Abstract

Available in full text

Date

November 6, 2018

Authors

Marcus-Hillert Schultze-Mosgau

Andrea Wagenfeld

Wolfgang Schwede

Publisher

Wiley

Related search

Efficacy and Safety of the Selective Progesterone Receptor Modulator (PRM) Vilaprisan - 24-Week Outcomes From Asteroid 2

Fertility and Sterility

Gynecology

Reproductive Medicine

Obstetrics

2018

English

Front Cover: Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis (ChemMedChem 14/2018)

English

Cover Picture: Development of Potent and Metabolically Stable APJ Ligands With High Therapeutic Potential (ChemMedChem 21/2016)

English

Front Cover: Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy (ChemMedChem 1/2018)

English

Front Cover: Synthesis of Trifluoromethyl-Α,β-Unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors (ChemMedChem 22/2018)

English

Non-Surgical Treatment of Uterine Fibroids. Efficacy of the Selective Progesterone Receptor Modulator

Medical Council

2019

English

Front Cover: The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders (ChemMedChem 13/2019)

English

Discovery of Vibegron: A Potent and Selective 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

English

Front Cover: A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma (ChemMedChem 15/2019)

English

Amanote Research

Front Cover: Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies (ChemMedChem 21/2018)

ChemMedChem - United Kingdom

doi 10.1002/cmdc.201800681

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Efficacy and Safety of the Selective Progesterone Receptor Modulator (PRM) Vilaprisan - 24-Week Outcomes From Asteroid 2

Front Cover: Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis (ChemMedChem 14/2018)

Cover Picture: Development of Potent and Metabolically Stable APJ Ligands With High Therapeutic Potential (ChemMedChem 21/2016)

Front Cover: Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy (ChemMedChem 1/2018)

Front Cover: Synthesis of Trifluoromethyl-Α,β-Unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors (ChemMedChem 22/2018)

Non-Surgical Treatment of Uterine Fibroids. Efficacy of the Selective Progesterone Receptor Modulator

Front Cover: The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders (ChemMedChem 13/2019)

Discovery of Vibegron: A Potent and Selective 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Front Cover: A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma (ChemMedChem 15/2019)